To enhance the value of TCIA collections we encourage the research community to publish their analyses of existing TCIA image collections. Examples of this kind of data includes radiologist or pathologist annotations, image classifications, segmentations, radiomics features, or derived/reprocessed images. Similar to submitting new image collections, these data are reviewed by the TCIA Advisory Group for relevance and curated using our normal processes to assure data are de-identified. However, TCIA does not certify the quality of the analyses themselves (e.g. accuracy of segmentation on a given scan). Researchers should always carefully review the data and any related publications before deciding whether these analyses could be useful in their work.
| Filter: | Use keywords in the filter box above the table to quickly find analysis results. |
| Sort: | Click any of the column headers to change the sorting method. |
| Collection | Cancer Types | Locations | Subjects | Related Collections | Supporting Data | Updated |
|---|---|---|---|---|---|---|
| ARAR0331-Tumor-Annotations | Nasopharyngeal | Head | 108 | ARAR0331 | Tumor segmentations, Seed points | 2023/11/14 |
| A091105-Tumor-Annotations | Non-Cancer | Various | 83 | A091105 | Tumor segmentations, Seed points | 2023/11/13 |
| ACRIN 6685-Tumor-Annotations | Head and Neck Squamous Cell Carcinoma | Head-Neck | 258 | ACRIN-HNSCC-FDG-PET-CT | Tumor segmentations, Seed points | 2023/11/13 |
| SAROS | Adenocarcinoma, Breast, Corpus Endometrial Carcinoma, COVID-19(non-cancer), Cutaneous Melanoma, Ductal Adenocarcinoma, Head and Neck Carcinomas, Head and Neck Squamous Cell Carcinoma, Healthy Controls (non-cancer), Kidney Cancer, Liver Hepatocellular Carcinoma, Lung Adenocarcinoma, Lung Cancer, Lung Squamous Cell Carcinoma, Melanoma, Non-small Cell Lung Cancer, Soft-tissue Sarcoma, Squamous Cell Carcinoma, Stomach Adenocarcinoma, Uterine Corpus Endometrial Carcinoma | Breast, Chest, Extremities, Head-Neck, Kidney, Liver, Lung, Pancreas, Skin, Stomach, Uterus | 882 | ACRIN-NSCLC-FDG-PET, CPTAC-LSCC, SOFT-TISSUE-SARCOMA, NSCLC-RADIOGENOMICS, LUNG-PET-CT-DX, NSCLC-RADIOMICS, LIDC-IDRI, TCGA-LUAD, TCGA-STAD, ANTI-PD-1_MELANOMA, TCGA-UCEC, CPTAC-CM, TCGA-LUSC, ACRIN-FLT-BREAST, ANTI-PD-1_LUNG, HNSCC, QIN-HEADNECK, CPTAC-LUAD, C4KC-KITS, HEAD-NECK-CETUXIMAB, TCGA-LIHC, CPTAC-PDA, NSCLC-RADIOMICS-GENOMICS, ACRIN-HNSCC-FDG-PET-CT, PANCREAS-CT, TCGA-HNSC, COVID-19-NY-SBU | Segmentations | 2023/09/28 |
| RSNA-ASNR-MICCAI-BraTS-2021 | Glioma | Brain | 1,480 | TCGA-LGG, UPENN-GBM, TCGA-GBM, IVYGAP, UCSF-PDGM, ACRIN-FMISO-BRAIN, CPTAC-GBM | Tumor segmentations | 2023/08/25 |
| AREN0532-Tumor-Annotations | Wilms Tumor | Kidney | 543 | AREN0532 | Tumor segmentations, Seed points | 2023/08/09 |
| ACNS0332-Tumor-Annotations | Medulloblastoma | Head | 85 | ACNS0332 | Tumor segmentations, Seed points | 2023/08/03 |
| CPTAC-CCRCC-Tumor-Annotations | Clear Cell Carcinoma | Kidney | 60 | CPTAC-CCRCC | Tumor segmentations, Seed points | 2023/07/24 |
| CPTAC-HNSCC-Tumor-Annotations | Head and Neck Squamous Cell Carcinoma | Head-Neck | 101 | CPTAC-HNSCC | Tumor segmentations, Seed points | 2023/07/24 |
| CPTAC-PDA-Tumor-Annotations | Ductal Adenocarcinoma | Pancreas | 103 | CPTAC-PDA | Tumor segmentations, Seed points | 2023/07/24 |
| CPTAC-UCEC-Tumor-Annotations | Corpus Endometrial Carcinoma | Uterus | 72 | CPTAC-UCEC | Tumor segmentations, Seed points | 2023/07/24 |
| QIBA-VolCT-1B | Lung | Lung | 40 | RIDER-PILOT, RIDER-LUNG-CT | Tumor segmentations, image features | 2023/05/24 |
| IvyGAP-Radiomics | Glioblastoma | Brain | 37 | IVYGAP | Tumor segmentations, radiomic features | 2023/04/23 |
| CALGB50303-Tumor-Annotations | Lymphoma | Various | 155 | CALGB50303 | Tumor segmentations, Seed points | 2023/03/30 |
| AHOD0831-Tumor-Annotations | Hodgkin Lymphoma | Various | 165 | AHOD0831 | Tumor segmentations, Seed points | 2023/02/10 |
| AREN0534-Tumor-Annotations | Wilms Tumor | Kidney | 239 | AREN0534 | Tumor segmentations, Seed points | 2023/02/08 |
| AREN0533-Tumor-Annotations | Wilms Tumor | Kidney | 294 | AREN0533 | Tumor segmentations, Seed points | 2023/01/31 |
| Radiomics outcome prediction in Oropharyngeal cancer | HNSCC | 2022/08/02 | ||||
| ISPY1-Tumor-SEG-Radiomics | Breast | Breast | 163 | ISPY1 | Tumor segmentations, radiomic features | 2022/06/01 |
| RIDER-LungCT-Seg | Lung | Chest | 31 | RIDER-LUNG-CT | Tumor segmentations | 2021/10/28 |
| PROSTATEx-Seg-Zones | Prostate | Prostate | 98 | PROSTATEX | Organ segmentations | 2020/11/25 |
| TCGA-GBM-QI-Radiogenomics | Glioblastoma | Brain | 55 | TCGA-GBM | Tumor segmentations | 2020/10/07 |
| PROSTATEx-Seg-HiRes | Prostate | Prostate | 66 | PROSTATEX | Organ segmentations | 2020/09/18 |
| PleThora | Lung | Lung | 402 | NSCLC-RADIOMICS | Thoracic segmentations, pleural effusion segmentations, image features | 2020/07/28 |
| MRQy-Quality-Measures | Glioblastoma, Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma | Brain, Cervix | 233 | CPTAC-GBM, TCGA-CESC, TCGA-GBM | Image quality assessment measures | 2020/07/16 |
| Radiomic-Feature-Standards | Lung | Chest | 13 | DRO-TOOLKIT, LIDC-IDRI | Multi-center comparison of radiomic features. | 2020/06/09 |
| DICOM-SR-Breast-Clinical | Breast | Breast | 474 | BREAST-MRI-NACT-PILOT, BREAST-DIAGNOSIS, ISPY1, TCGA-BRCA | DICOM SR descriptions of patient characteristics, histopathology, receptor status and clinical findings including measurements. | 2020/05/26 |
| DICOM-Glioma-SEG | Glioblastoma, Low Grade Glioma | Brain | 167 | TCGA-LGG, TCGA-GBM | Tumor segmentations | 2020/04/30 |
| TCGA-OV-Proteogenomics | Ovarian | Ovary | 20 | TCGA-OV | Radiologist assessments of image features, proteogenomic features | 2020/04/06 |
| DICOM-LIDC-IDRI-Nodules | Lung | Chest | 875 | LIDC-IDRI | Tumor segmentations, image features | 2020/03/26 |
| Radiomics-Tumor-Phenotypes | NSCLC-RADIOMICS-INTEROBSERVER1, NSCLC-RADIOMICS-GENOMICS, HEAD-NECK-RADIOMICS-HN1, NSCLC-RADIOMICS | 2020/03/23 | ||||
| Pan-Cancer-Nuclei-Seg | Bladder Urothelial Carcinoma, Breast Invasive Carcinoma, Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, Glioblastoma Multiforme, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Pancreatic adenocarcinoma, Prostate Adenocarcinoma, Skin Cutaneous Melanoma, Uterine Corpus Endometrial Carcinoma, Colon adenocarcinoma, Rectal Adenocarcinoma, Stomach Adenocarcinoma, Uveal Melanoma | Bladder, Brain, Breast, Colon, Eye, Lung, Pancreas, Prostate, Rectum, Stomach, Uterus, Endometrium | TCGA-CESC, TCGA-BLCA, TCGA-LUAD, TCGA-COAD, TCGA-STAD, TCGA-GBM, TCGA-BRCA, TCGA-PRAD, TCGA-UCEC, TCGA-LUSC, TCGA-READ | Nuclei segmentations | 2020/02/08 | |
| Head-Neck-CT-Atlas | Head and Neck Squamous Cell Carcinoma | Head-Neck | 215 | HNSCC | Radiation Therapy Structures | 2019/07/11 |
| DI-Cubed-Reports | Breast, Glioblastoma | Breast, Brain | 516 | BREAST-DIAGNOSIS, ISPY1, IVYGAP, TCGA-BRCA, BREAST-MRI-NACT-PILOT | Standardized (SDTM format) conversions of clinical and image analysis data | 2019/06/21 |
| Crowds-Cure-2018 | Bladder Endothelial Carcinoma, Colon adenocarcinoma, Glioblastoma Multiforme, Head and Neck Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma, Melanoma, Non-small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Renal Clear Cell Carcinoma, Uterine Corpus Endometrial Carcinoma | Bladder, Brain, Colon, Head-Neck, Kidney, Lung, Pancreas, Skin, Uterine corpus | 324 | CPTAC-GBM, CPTAC-CCRCC, TCGA-BLCA, CPTAC-PDA, TCGA-COAD, NSCLC-RADIOGENOMICS, ANTI-PD-1_MELANOMA, TCGA-HNSC, TCGA-UCEC, CPTAC-HNSCC, TCGA-LUSC, ANTI-PD-1_LUNG, CPTAC-UCEC | Lesion measurements | 2019/05/30 |
| QIN-LungCT-Seg | Lung | Chest | 31 | LIDC-IDRI, RIDER-LUNG-CT, QIN-LUNG-CT, LUNG-PHANTOM | Tumor segmentations | 2018/12/18 |
| TIL-WSI-TCGA | Bladder Urothelial Carcinoma, Breast Invasive Carcinoma, Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, Colon adenocarcinoma, Lung Adenocarcinoma, Lung Squamous Cell Carcinoma, Pancreatic adenocarcinoma, Prostate Adenocarcinoma, Rectum Adenocarcinoma, Skin Cutaneous Melanoma, Stomach Adenocarcinoma, Uterine Corpus Endometrial Carcinoma, Uveal Melanoma | Bladder, Breast, Pelvic Cervix, Chest, Colon, Eye, Lung, Pancreas, Prostate, Rectum, Skin, Stomach, Uterus | 4,759 | Deep learning based computational stain for staining tumor-infiltrating lymphocytes (TILs) | 2018/12/17 | |
| TCGA-Breast-Radiogenomics | Breast | Breast | 84 | TCGA-BRCA | Radiologist assessments of image features, Tumor segmentations, radiomic features, multi-gene assays | 2018/09/04 |
| Crowds-Cure-2017 | Lung Adenocarcinoma, Renal Clear Cell, Liver, Ovarian | Chest, Kidney, Liver, Ovary | 352 | TCGA-KIRC, TCGA-LIHC, TCGA-OV, TCGA-LUAD | Lesion measurements | 2018/05/17 |
| LUAD-CT-Survival | Lung Adenocarcinoma | Chest | 40 | LUNGCT-DIAGNOSIS, QIN-LUNG-CT | Tumor segmentations, radiomic image features | 2017/08/11 |
| BraTS-TCGA-GBM | Glioblastoma | Brain | 135 | TCGA-GBM | Tumor segmentations, radiomic image features | 2017/07/17 |
| BraTS-TCGA-LGG | Low Grade Glioma | Brain | 108 | TCGA-LGG | Tumor segmentations, radiomic image features | 2017/07/17 |
| TCGA-LGG-Mask | Low Grade Glioma | Brain | 188 | TCGA-LGG | Radiologist assessments of image features, Tumor segmentations | 2017/03/17 |
| Image-Compression-Simulation | 37 | TCGA-GBM, TCGA-BRCA, CT COLONOGRAPHY, LIDC-IDRI | 2016/12/08 | |||
| TCGA-OV-Radiogenomics | High grade serous ovarian cancer | Ovary | 93 | Radiologist assessments of image features, genomic subtypes | 2016/08/02 | |
| ISBI-MR-Prostate-2013 | Prostate | Prostate | 80 | Prostate structure segmentations | 2015/08/20 | |
| Spatial-Features-MRI-GBM | TCGA-GBM | 2015/08/20 | ||||
| TCGA-KIRC-Radiogenomics | Renal Clear Cell Carcinoma | Kidney | 103 | TCGA-KIRC | Radiologist assessments of image features | 2015/05/28 |
| Pulmonary-Nodules-Segmentation | LIDC-IDRI | 2015/02/24 | ||||
| Glioblastoma-Genomic-Mapping | TCGA-GBM | 2014/12/11 | ||||
| LuminalB-Breast-MR-Enhancement | TCGA-BRCA | 2014/11/12 | ||||
| TCGA-GBM-Radiogenomics | Glioblastoma | Brain | 75 | TCGA-GBM | Radiologist assessments of image features | 2014/11/12 |
| GBM-MR-NER-Outcomes | Glioblastoma | Brain | 45 | TCGA-GBM | 2014/07/24 | |
| NSCLC Radiogenomics-Stanford | NSCLC-RADIOGENOMICS | 2013/03/01 |